Adverse Events—Laboratory Examinations
| Adverse event | Grade 1–2 | Grade 3 | Grade 4 | NA |
| γ-glutamyl transferase | 6 | 28 | 4 | 0 |
| Lymphocytopenia | 15 | 6 | 1 | 0 |
| Bilirubin | 12 | 0 | 1 | 0 |
| Alkaline phosphatase | 32 | 6 | 0 | 0 |
| Aspartate aminotransferase | 35 | 3 | 0 | 0 |
| Alanine aminotransferase | 28 | 2 | 0 | 0 |
| Lactate dehydrogenase | 27 | 0 | 0 | 0 |
| Hemoglobin | 26 | 0 | 0 | 0 |
| Ammonia | 22 | 0 | 0 | 0 |
| Albumin | 20 | 0 | 0 | 0 |
| Platelet count | 19 | 0 | 0 | 0 |
| Erythrocytes | 15 | 0 | 0 | 0 |
| Sodium | 15 | 0 | 0 | 2 |
| Leukocytes | 14 | 0 | 0 | 0 |
| Creatinine | 12 | 0 | 0 | 0 |
| Potassium | 9 | 0 | 0 | 2 |
| Total protein | 9 | 0 | 0 | 4 |
| Calcium (ionized) | 8 | 0 | 0 | 3 |
| Magnesium | 6 | 0 | 0 | 4 |
| Phosphorus | 6 | 0 | 0 | 3 |
| Urea | 6 | 0 | 0 | 3 |
| Chloride | 5 | 0 | 0 | 4 |
| Bicarbonate | 4 | 0 | 0 | 4 |
NA = not available.
Maximum CTCAE grade of adverse event during follow-up after treatment is shown; some of these adverse events were preexistent.